FIELD: medicine, hematology. SUBSTANCE: invention relates to blood substitute as oxygen transporter that is an aqueous solution containing the following components, wt.%: polymeric modified hemoglobin, 0.9-1.1; sodium chloride, 1.0-1.2; glucose, 0.68-0.83; ascorbic acid, 0.023-0.027; and water up to 100. Invention relates to also the composition for preparing blood substitute as oxygen transporter containing, g per a single therapeutic dose (400 ml of solution): polymeric modified hemoglobin, 3.6-4.4; sodium chloride, 0.7-0.9; glucose, 2.7-3.3; ascorbic acid, 6°C-0.11. Polymeric modified hemoglobin is prepared by interaction of deoxyhemoglobin with glutaric aldehyde modified at pH 6.4-6.6 and 4-6 C with substance of an order including dicarboxylic amino acid and sodium bisulfite. EFFECT: efficiency of proposed blood substitute is comparable with that of gaseous transport with human blood. 4 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING POLYHEMOGLOBIN SHOWING ENHANCED OXYGEN-TRANSPORTING EFFECTIVENESS | 1996 |
|
RU2132687C1 |
METHOD FOR PREPARING POLYMER MODIFIED HEMOGLOBIN | 2012 |
|
RU2504387C2 |
PROCESS FOR PREPARING IMMOBILIZED DISMUTASE SUPEROXIDE | 1991 |
|
RU2046143C1 |
BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER, PHARMACEUTICAL COMPOSITION (VERSIONS) | 2008 |
|
RU2361608C1 |
METHOD OF BLOOD SUBSTITUTE PRODUCTION AND RELATED INSTALLATION FOR METHOD IMPLEMENTATION | 2007 |
|
RU2341286C1 |
TRIVALENT IRON FUMARATE HYDRATE AS AGENT FOR TREATING IRON-DEFICIENT ANEMIA PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 1997 |
|
RU2161963C2 |
POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
PRESERVING AGENT FOR WASHED OUT ERYTHROCYTES | 2002 |
|
RU2225692C2 |
METHOD OF NORMAL PLASMA POOL PREPARING | 2000 |
|
RU2174841C1 |
ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
Authors
Dates
2001-02-10—Published
1999-03-24—Filed